462 related articles for article (PubMed ID: 29242313)
1. Dissection of Glomerular Transcriptional Profile in Patients With Diabetic Nephropathy: SRGAP2a Protects Podocyte Structure and Function.
Pan Y; Jiang S; Hou Q; Qiu D; Shi J; Wang L; Chen Z; Zhang M; Duan A; Qin W; Zen K; Liu Z
Diabetes; 2018 Apr; 67(4):717-730. PubMed ID: 29242313
[TBL] [Abstract][Full Text] [Related]
2. Impact of klotho on the expression of SRGAP2a in podocytes in diabetic nephropathy.
Jin D; Jia M; Xie Y; Lin L; Qiu H; Lu G
BMC Nephrol; 2022 Apr; 23(1):151. PubMed ID: 35436879
[TBL] [Abstract][Full Text] [Related]
3. RhoA protects the podocytes against high glucose-induced apoptosis through YAP and plays critical role in diabetic nephropathy.
Huang Z; Peng Y; Yu H; Yu X; Zhou J; Xiao J
Biochem Biophys Res Commun; 2018 Oct; 504(4):949-956. PubMed ID: 30220545
[TBL] [Abstract][Full Text] [Related]
4. Loss of PTEN promotes podocyte cytoskeletal rearrangement, aggravating diabetic nephropathy.
Lin J; Shi Y; Peng H; Shen X; Thomas S; Wang Y; Truong LD; Dryer SE; Hu Z; Xu J
J Pathol; 2015 May; 236(1):30-40. PubMed ID: 25641678
[TBL] [Abstract][Full Text] [Related]
5. Podocyte-specific loss of Cdc42 leads to congenital nephropathy.
Scott RP; Hawley SP; Ruston J; Du J; Brakebusch C; Jones N; Pawson T
J Am Soc Nephrol; 2012 Jul; 23(7):1149-54. PubMed ID: 22518006
[TBL] [Abstract][Full Text] [Related]
6. GSK-3β inhibitor attenuates urinary albumin excretion in type 2 diabetic db/db mice, and delays epithelial-to-mesenchymal transition in mouse kidneys and podocytes.
Wan J; Li P; Liu DW; Chen Y; Mo HZ; Liu BG; Chen WJ; Lu XQ; Guo J; Zhang Q; Qiao YJ; Liu ZS; Wan GR
Mol Med Rep; 2016 Aug; 14(2):1771-84. PubMed ID: 27357417
[TBL] [Abstract][Full Text] [Related]
7. The Rho-GTPase binding protein IQGAP2 is required for the glomerular filtration barrier.
Sugano Y; Lindenmeyer MT; Auberger I; Ziegler U; Segerer S; Cohen CD; Neuhauss SC; Loffing J
Kidney Int; 2015 Nov; 88(5):1047-56. PubMed ID: 26154927
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of low-density lipoprotein receptor contributes to podocyte injuries in diabetic nephropathy.
Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Liu BC
Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1140-8. PubMed ID: 25921580
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
[TBL] [Abstract][Full Text] [Related]
10. Profile of Podocyte Translatome During Development of Type 2 and Type 1 Diabetic Nephropathy Using Podocyte-Specific TRAP mRNA RNA-seq.
Wang Y; Niu A; Pan Y; Cao S; Terker AS; Wang S; Fan X; Toth CL; Ramirez Solano MA; Michell DL; Contreras D; Allen RM; Zhu W; Sheng Q; Fogo AB; Vickers KC; Zhang MZ; Harris RC
Diabetes; 2021 Oct; 70(10):2377-2390. PubMed ID: 34233930
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of podocyte lesion in patients with diabetic nephropathy: Wilms' tumor-1 protein used as a podocyte marker.
Su J; Li SJ; Chen ZH; Zeng CH; Zhou H; Li LS; Liu ZH
Diabetes Res Clin Pract; 2010 Feb; 87(2):167-75. PubMed ID: 19969384
[TBL] [Abstract][Full Text] [Related]
12. Variations in MicroRNA-25 Expression Influence the Severity of Diabetic Kidney Disease.
Liu Y; Li H; Liu J; Han P; Li X; Bai H; Zhang C; Sun X; Teng Y; Zhang Y; Yuan X; Chu Y; Zhao B
J Am Soc Nephrol; 2017 Dec; 28(12):3627-3638. PubMed ID: 28923913
[TBL] [Abstract][Full Text] [Related]
13. Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy.
Tagawa A; Yasuda M; Kume S; Yamahara K; Nakazawa J; Chin-Kanasaki M; Araki H; Araki S; Koya D; Asanuma K; Kim EH; Haneda M; Kajiwara N; Hayashi K; Ohashi H; Ugi S; Maegawa H; Uzu T
Diabetes; 2016 Mar; 65(3):755-67. PubMed ID: 26384385
[TBL] [Abstract][Full Text] [Related]
14. Podocyte EGFR Inhibits Autophagy Through Upregulation of Rubicon in Type 2 Diabetic Nephropathy.
Li Y; Pan Y; Cao S; Sasaki K; Wang Y; Niu A; Fan X; Wang S; Zhang MZ; Harris RC
Diabetes; 2021 Feb; 70(2):562-576. PubMed ID: 33239448
[TBL] [Abstract][Full Text] [Related]
15. Synaptopodin protects against proteinuria by disrupting Cdc42:IRSp53:Mena signaling complexes in kidney podocytes.
Yanagida-Asanuma E; Asanuma K; Kim K; Donnelly M; Young Choi H; Hyung Chang J; Suetsugu S; Tomino Y; Takenawa T; Faul C; Mundel P
Am J Pathol; 2007 Aug; 171(2):415-27. PubMed ID: 17569780
[TBL] [Abstract][Full Text] [Related]
16. Podocyte-specific deletion of Rac1 leads to aggravation of renal injury in STZ-induced diabetic mice.
Ishizaka M; Gohda T; Takagi M; Omote K; Sonoda Y; Oliva Trejo JA; Asao R; Hidaka T; Asanuma K; Horikoshi S; Tomino Y
Biochem Biophys Res Commun; 2015 Nov; 467(3):549-55. PubMed ID: 26435502
[TBL] [Abstract][Full Text] [Related]
17. PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease.
Zhang Z; Liang W; Luo Q; Hu H; Yang K; Hu J; Chen Z; Zhu J; Feng J; Zhu Z; Chi Q; Ding G
Front Endocrinol (Lausanne); 2021; 12():797025. PubMed ID: 35095764
[TBL] [Abstract][Full Text] [Related]
18. Dosage-dependent role of Rac1 in podocyte injury.
Wan X; Lee MS; Zhou W
Am J Physiol Renal Physiol; 2016 Apr; 310(8):F777-F784. PubMed ID: 26792065
[TBL] [Abstract][Full Text] [Related]
19. The transcription factor Dach1 is essential for podocyte function.
Endlich N; Kliewe F; Kindt F; Schmidt K; Kotb AM; Artelt N; Lindenmeyer MT; Cohen CD; Döring F; Kuss AW; Amann K; Moeller MJ; Kabgani N; Blumenthal A; Endlich K
J Cell Mol Med; 2018 May; 22(5):2656-2669. PubMed ID: 29498212
[TBL] [Abstract][Full Text] [Related]
20. The reno-protective effect of a phosphoinositide 3-kinase inhibitor wortmannin on streptozotocin-induced proteinuric renal disease rats.
Kim SH; Jang YW; Hwang P; Kim HJ; Han GY; Kim CW
Exp Mol Med; 2012 Jan; 44(1):45-51. PubMed ID: 22056625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]